TargetMol

DuP-532

Product Code:
 
TAR-T27219
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T27219-5mg5mg£1,171.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27219-50mg50mg£2,303.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27219-100mg100mg£3,042.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
DuP-532, an angiotensin type 1 receptor antagonist, is used potentially for the treatment of hypertension and heart failure.
CAS:
124750-95-4
Formula:
C23H19F5N6O2
Molecular Weight:
506.437
Purity:
0.98
SMILES:
CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)C(F)(F)C(F)(F)F

References

1. Maillard MP, Centeno C, Frostell-Karlsson ?, Brunner HR, Burnier M. Does protein binding modulate the effect of angiotensin II receptor antagonists? J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1_suppl):S54-S58. doi: 10.1177/14703203010020010901. PubMed PMID: 28095232. 2. Maurin MB, Taylor A. Variable heating rate thermogravimetric analysis as a mechanism to improve efficiency and resolution of the weight loss profiles of three model pharmaceuticals. J Pharm Biomed Anal. 2000 Nov;23(6):1065-71. PubMed PMID: 11095309. 3. De Witt BJ, Garrison EA, Champion HC, Kadowitz PJ. L-163,491 is a partial angiotensin AT(1) receptor agonist in the hindquarters vascular bed of the cat. Eur J Pharmacol. 2000 Sep 15;404(1-2):213-9. PubMed PMID: 10980281. 4. Champion HC, Estrada LS, Estrada LN, Filep JG, Kadowitz PJ. Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat. Can J Physiol Pharmacol. 1998 Feb;76(2):141-7. PubMed PMID: 9635152.